Table 1. Summary of study design.
Study component | Dose (ml/kg) | n patients | Type of MR acquisition |
---|---|---|---|
Phase 1: Dose escalation | 0.14 | 3 | 1D dynamic MRSI |
3 | 3D MRSI | ||
0.28 | 3 | 1D dynamic MRSI | |
3 | 3D MRSI | ||
0.43 | 3 | 1D dynamic MRSI | |
3 | 2D MRSI | ||
Phase 2: Refining MR methods | 0.43 | 5 | 2D dynamic MRSI |
3 | 2D MRSI | ||
5 | 3D MRSI |